文献速递甲状腺与浅表头颈USCTMRPET

甲状腺良性细针穿刺活检后患者的影像监测:相关费用与后续癌症发生率

Imaging Surveillance in Patients After a Benign Fine-Needle Aspiration Biopsy of the Thyroid: Associated Cost and Incidence of Subsequent Cancer.
PubMed 文献 · AJR Am J Roentgenol · 2016-12-08

该队列研究纳入1999年1月1日至2003年12月31日间1685例甲状腺良性细针穿刺活检患者,其中800例(47.5%)接受随访影像,平均随访7.3年,19例(2.4%)诊断为甲状腺癌,随访影像总费用879347美元(每例患者1099美元),每检出1例癌症费用46281美元。

要点

  • 甲状腺良性细针穿刺活检后约半数患者接受随访影像,恶性检出率低(2.4%)。
  • 随访影像总费用879347美元,每例患者1099美元,每检出1例癌症费用46281美元。
  • 随访影像包括甲状腺超声2223次、超声引导下甲状腺细针穿刺活检606次、甲状腺核素显像78次、颈部CT 168次、颈部MRI 53次。

核心结论

  • 在5年期间,约半数甲状腺良性细针穿刺活检患者接受随访影像,费用可观,而后续恶性检出率低。

研究设计与样本

  • 队列研究,经机构审查委员会批准并符合HIPAA,纳入1999年1月1日至2003年12月31日间1685例甲状腺良性细针穿刺活检患者,从机构病理数据库和电子病历收集影像监测与后续癌症检测信息,费用按设施总相对价值单位和2014年医院门诊前瞻性支付系统转换因子确定。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The objective of our study was to determine patterns and cost of imaging tumor surveillance in patients after a benign fine-needle aspiration (FNA) biopsy of the thyroid in a large teaching hospital as well as the rate of subsequent cancer detection.

MATERIALS AND METHODS: This cohort study was approved by the appropriate institutional review board and complied with HIPAA. All patients who had a benign thyroid FNA biopsy between January 1, 1999, and December 31, 2003, were identified from an institutional pathology database. We gathered information from electronic medical records on imaging tumor surveillance and subsequent cancer detection. Cost was determined using the facility total relative value unit and the 2014 Hospital Outpatient Prospective Payment System conversion factor.

RESULTS: Between January 1, 1999, and December 31, 2003, 1685 patients had a benign thyroid FNA biopsy, 800 (47.5%) of whom underwent follow-up imaging. These patients underwent 2223 thyroid ultrasound examinations, 606 ultrasound-guided thyroid FNA biopsies, 78 thyroid scintigraphy examinations, 168 neck CTs, and 53 neck MRIs at a cost of $529,874, $176,157, $39,622, $80,580, and $53,114, respectively, for a total cost of $879,347 or $1099 per patient. The mean length of follow-up was 7.3 years, during which time 19 (2.4%) patients were diagnosed with thyroid cancer at a cost of $46,281 per cancer. Seventeen (89.5%) were diagnosed with papillary carcinoma and two (10.5%) with Hurthle cell carcinoma.

CONCLUSION: Over a 5-year period, about half of the patients who had a benign thyroid FNA biopsy underwent follow-up imaging at considerable cost with a small rate of subsequent malignancy.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Becker-Weidman DJ, Malhotra N, Reilly DF, et al. Imaging Surveillance in Patients After a Benign Fine-Needle Aspiration Biopsy of the Thyroid: Associated Cost and Incidence of Subsequent Cancer. AJR Am J Roentgenol. 2016. PMID: 27929675. doi:10.2214/AJR.16.16691

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。